PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Respiratory Diseases, KU Leuven University Hospitals, Leuven, Flanders, Belgium iwein.gyselinck@kuleuven.be.\', \'Department CHROMETA - Research group BREATHE, KU Leuven, Leuven, Flanders, Belgium.\', \'Respiratory Diseases, KU Leuven University Hospitals, Leuven, Flanders, Belgium.\', \'Cardiovascular Diseases, KU Leuven University Hospitals, Leuven, Flanders, Belgium.\', \'Centre for Molecular and Vascular Biology, KU Leuven, Leuven, Flanders, Belgium.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • e00080610.1136/bmjresp-2020-000806
?:hasPublicationType
?:journal
  • BMJ open respiratory research
is ?:pmid of
?:pmid
?:pmid
  • 33441373
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.188
?:rankingScore_hIndex
  • 10
is ?:relation_isRelatedTo_publication of
?:title
  • Rationale for azithromycin in COVID-19: an overview of existing evidence.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33441373>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33441373>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all